Dr. Hafrun Fridriksdottir

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Teva Pharmaceutical Industries Ltd (TEVA)
Board Member

Proxy statement

Current
2017-01-01–present
Teva Pharmaceutical Industries Ltd (TEVA)
Proxy statement

Start not stated–2022-06-20

Recorded roles and earnings-call appearances connecting this person to public companies.

TEVA

Current role

Board Member

2017-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2020	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$562,500	$1,999,987	$0	$828,576	$179,270	$4,290,333
2019	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$837,500	$1,899,988	$0	$734,832	$185,405	$4,377,725
2018	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$720,000	$650,000	$2,321,392	$900,003	$1,296,144	$87,492	$5,975,031
2017	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, GlobalResearch and Development	$696,346	$900,000	$999,957	$500,047	$535,000	$77,492	$3,708,842

No earnings-call appearances or filed executive changes recorded yet.